The Clinical Analysis of Paclitaxel at Two Dose Levels plus Carboplatin as the First-line Treatment in Advanced Non-small Cell Lung Cancer
Background and objective The combination of pacilitaxel and carboplatin has become a widely used regimen in first-line therapy of advanced NSCLC. The aim of this study is to compare the efficacy and safety of paclitaxel plus carboplatin at two dose levels in the first-line treatment of advanced NSCL...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Chinês |
| Pubblicazione: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2011-04-01
|
| Serie: | Chinese Journal of Lung Cancer |
| Soggetti: | |
| Accesso online: | http://www.lungca.org/index.php?journal=01&page=article&op=viewFile&path[]=10.3779%2Fj.issn.1009-3419.2011.04.04&path[]=3730 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|